Related Experiment Video
Updated: Jun 28, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
Coronavirus Disease 2019: Past, Present, and Future
Charlotte Page Wills1, Berenice Perez1, Justin Moore1
1Department of Emergency Medicine, Alameda Health System, Wilma Chan Highland Hospital, Oakland, California, 1411 East 31st Street, Oakland, CA 94602, USA.
Emergency Medicine Clinics of North America
|April 19, 2024
Summary
The COVID-19 pandemic continues with new variants like EG.5 and BA.2.86 emerging. This article reviews pandemic lessons, current COVID-19 management, and future disease directions.
Area of Science:
- Infectious Diseases
- Public Health
- Virology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic.
- Despite the 2023 health emergency conclusion, coronavirus disease 2019 (COVID-19) remains a significant public health concern due to ongoing viral mutations.
- New variants, including EG.5 and the distinct Omicron descendant BA.2.86, have emerged globally.
Purpose of the Study:
- To provide lessons learned from the COVID-19 pandemic.
- To summarize the best available evidence for the current management of COVID-19 patients.
- To offer insights into future directions for managing this evolving disease.
Main Methods:
- Literature review of pandemic-related data.
- Synthesis of current clinical guidelines for COVID-19 management.
- Analysis of emerging variant trends and their implications.
Main Results:
- The pandemic has provided critical insights into public health responses and disease management.
- Current management strategies are informed by evolving evidence on viral characteristics and treatment efficacy.
- Emerging variants necessitate continuous adaptation of public health strategies and clinical practice.
Conclusions:
- Ongoing vigilance and adaptation are crucial for managing COVID-19.
- Future efforts should focus on preparedness for new variants and sustained public health measures.
- A comprehensive understanding of lessons learned will inform future pandemic responses.
Related Concept Videos
01:18Steps in Outbreak Investigation
125
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
125
01:20COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267
01:05Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
01:20Infection
7.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.9K
00:36Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
01:51Vaccinations
44.4K
Overview
44.4K